Abemaciclib, palbociclib and ribociclib are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.
- Abemaciclib (Verzenio®, Verzenios®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.
- Palbociclib (Ibrance®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.
- Ribociclib (Kisqali®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.